The role of HIV-related chemokine receptors and chemokines in human erythropoiesis in vitro. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The role of HIV-related chemokine receptors and chemokines in human erythropoiesis in vitro.

Stem Cells. 2000;18(2):128-38. Unique Identifier : AIDSLINE MED/20209089
Majka M; Ratajczak J; Lee B; Honczarenko M; Douglas R; Kowalska MA; Silberstein L; Gewirtz AM; Ratajczak MZ; Department of Pathology & Laboratory Medicine, Children's; Hospital of Philadelphia, PA 19104, USA.


Abstract: In order to better define the role of HIV-related chemokines in human erythropoiesis we studied: A) the expression of chemokine receptors, both on human CD34(+) cells which include erythroid progenitors and on more mature erythroid cells; B) the functionality of these receptors by calcium flux, chemotaxis assay and phosphorylation of mitogen-activated protein kinases (MAPK) p42/44 (ERK1/ERK2) and AKT, and finally C) the influence of chemokines on BFU-E formation. We found that HIV-related chemokine receptor CXCR4, but not CCR5, is detectable on human CD34(+) BFU-E cells. CXCR4 surface expression decreased during erythroid maturation, although CXCR4 mRNA was still present in cells isolated from differentiated erythroid colonies. SDF-1, a CXCR4 ligand, induced calcium flux and phosphorylation of MAPK (p42/44) and AKT in CD34(+)KIT(+) bone marrow mononuclear cells which contain BFU-E, as well as chemotactic activity of both human CD34(+) BFU-E progenitors and erythroid cells isolated from day 2-6 BFU-E colonies. Responsiveness to SDF-1 decreased when the cells differentiated to the point of surface expression of the erythroid-specific marker Glycophorin-A. In contrast, the CCR5 ligands (macrophage inflammatory protein-1alpha [MIP-1alpha], MIP-1beta, and RANTES) did not activate calcium flux, MAPK and AKT phosphorylation or chemotaxis of CD34(+)KIT(+) cells or cells isolated from the BFU-E colonies. Interestingly, none of the chemokines tested in this study had any effect on BFU-E colony formation. In conclusion, only CXCR4 is functional, and its specific ligand SDF-1 may therefore play an important role in the homing and/or retention of early erythroid precursors in the bone marrow environment.
Keywords: JOURNAL ARTICLE p42 MAP Kinase/METABOLISM Antigens, CD34 Calcium/METABOLISM Cell Division Cells, Cultured Chemokines/*PHYSIOLOGY Chemotaxis Culture Media, Serum-Free Erythroid Progenitor Cells/CYTOLOGY/METABOLISM Erythropoiesis/*PHYSIOLOGY Gene Expression Hematopoietic Stem Cells/CYTOLOGY/METABOLISM Human HIV/*METABOLISM Ligands Mitogen-Activated Protein Kinases/METABOLISM Phosphorylation Receptors, Chemokine/GENETICS/*PHYSIOLOGY Support, U.S. Gov't, P.H.S.

KWDjournalarticlep42mapkinase/metabolismantigens,cd34calcium/metabolismcelldivisioncells,culturedchemokines/KWDphysiologychemotaxisculturemedia,serum-freeerythroidprogenitorcells/cytology/metabolismerythropoiesis/KWDphysiologygeneexpressionhematopoieticstemcells/cytology/metabolismhumanhiv/KWDmetabolismligandsmitogen-activatedproteinkinases/metabolismphosphorylationreceptors,chemokine/genetics/KWDphysiologysupport,uKWDsKWDgov't,pKWDhKWDs
000930
A0091471


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .